Literature DB >> 6725403

Preparation of nuclear matrices from cultured cells: subfractionation of nuclei in situ.

M Staufenbiel, W Deppert.   

Abstract

Analyses of the different structural systems of the nucleus and the proteins associated with them pose many problems. Because these systems are largely overlapping, in situ localization studies that preserve the in vivo location of proteins and cellular structures often are not satisfactory. In contrast, biochemical cell fractionation may provide artifactual results due to cross-contamination of extracts and structures. To overcome these problems, we have developed a method that combines biochemical cell fractionation and in situ localization and leads to the preparation of a residual cellular skeleton (nuclear matrix and cytoskeletal elements) from cultured cells. This method's main feature is that cell fractionation is performed in situ. Therefore, structures not solubilized in a particular extraction step remain attached to the substrate and retain their morphology. Before and after each extraction step they can be analyzed for the presence and location of the protein under study by using immunological or cytochemical techniques. Thereby the in vivo origin of a protein solubilized in a particular extraction step is determined. The solubilized protein then may be further characterized biochemically. In addition, to allow analyses of proteins associated with the residual cellular skeleton, we have developed conditions for its solubilization that do not interfere with enzymatic and immunological studies.

Mesh:

Substances:

Year:  1984        PMID: 6725403      PMCID: PMC2113189          DOI: 10.1083/jcb.98.5.1886

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  61 in total

1.  The cytoskeletal framework and poliovirus metabolism.

Authors:  R Lenk; S Penman
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

Review 2.  Viral 'tumor antigens': A novel type of mammalian regulator protein.

Authors:  R Weil
Journal:  Biochim Biophys Acta       Date:  1978-11-17

3.  Different structural systems of the nucleus are targets for SV40 large T antigen.

Authors:  M Staufenbiel; W Deppert
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

4.  Functional differences between mammalian nuclear protein matrices and pore-lamina complex laminae.

Authors:  P S Agutter; K Birchall
Journal:  Exp Cell Res       Date:  1979-12       Impact factor: 3.905

5.  Analysis of the attachment of replicating DNA to a nuclear matrix in mammalian interphase nuclei.

Authors:  P A Dijkwel; L H Mullenders; F Wanka
Journal:  Nucleic Acids Res       Date:  1979-01       Impact factor: 16.971

6.  Simian virus 40 T- and U-antigens: immunological characterization and localization in different nuclear subfractions of simian virus 40-transformed cells.

Authors:  W Deppert
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

7.  Simian virus 40 (SV40)-specific proteins associated with the nuclear matrix isolated from adenovirus type 2-SV40 hybrid virus-infected HeLa cells carry SV40 U-antigen determinants.

Authors:  W Deppert
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

8.  Isolation of a residual protein structure from nuclei of the myxomycete Physarum polycephalum.

Authors:  K R Mitchelson; A G Bekers; F Wanka
Journal:  J Cell Sci       Date:  1979-10       Impact factor: 5.285

9.  DNA-binding properties of nuclear matrix proteins.

Authors:  D E Comings; A S Wallack
Journal:  J Cell Sci       Date:  1978-12       Impact factor: 5.285

10.  Heterogeneous nuclear RNA-protein fibers in chromatin-depleted nuclei.

Authors:  R Herman; L Weymouth; S Penman
Journal:  J Cell Biol       Date:  1978-09       Impact factor: 10.539

View more
  48 in total

1.  Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

Authors:  M Bui; E G Wills; A Helenius; G R Whittaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Baculovirus phosphoprotein pp31 is associated with virogenic stroma.

Authors:  L A Guarino; W Dong; B Xu; D R Broussard; R W Davis; D L Jarvis
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Specific interaction of simian virus 40 large T antigen with cellular chromatin and nuclear matrix during the course of infection.

Authors:  R Schirmbeck; W Deppert
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent.

Authors:  K Chida; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants.

Authors:  U Knippschild; J Kiefer; T Patschinsky; W Deppert
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Identification of a phosphoprotein in the nuclear matrix by monoclonal antibodies.

Authors:  M J Halikowski; C C Liew
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

7.  Functional interaction of nuclear transport-defective simian virus 40 large T antigen with chromatin and nuclear matrix.

Authors:  W Deppert; A Von Der Weth
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  cDNA cloning and functional characterization of a meiosis-specific protein (MNS1) with apparent nuclear association.

Authors:  K Furukawa; H Inagaki; T Naruge; S Tabata; T Tomida; A Yamaguchi; M Yoshikuni; Y Nagahama; Y Hotta
Journal:  Chromosome Res       Date:  1994-03       Impact factor: 5.239

9.  Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity.

Authors:  D P Gately; J C Hittle; G K Chan; T J Yen
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

10.  Detection and intracellular localization of equine herpesvirus 1 IR1 and IR2 gene products by using monoclonal antibodies.

Authors:  G B Caughman; J B Lewis; R H Smith; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.